PIM
TEVA icon

Plato Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Plato Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
9,185
-8,583
-48% -$286K 0.02% 380
2026
Q1 		$535K Buy
17,768
+14,879
+515% +$479K 0.04% 341
2025
Q4 		$90.6K Sell
2,889
-86
-3% -$2.12K 0.01% 421
2025
Q3 		$59.6K Hold
2,975
– – ﹤0.01% 436
2025
Q2 		$49.7K Sell
2,975
-18,787
-86% -$303K ﹤0.01% 450
2025
Q1 		$338K Sell
21,762
-24,495
-53% -$438K 0.03% 361
2024
Q4 		$1.02M Sell
46,257
-17,273
-27% -$314K 0.08% 250
2024
Q3 		$1.14M Buy
+63,530
New +$1.11M 0.09% 228

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Plato Investment Management's TEVA Position: Q2 2026 in Review

Plato Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 48% in Q2 2026, selling an estimated $286K and leaving 9,185 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #380.

Plato Investment Management first reported a position in TEVA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.14M in Q3 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Plato Investment Management held 9,185 shares of Teva Pharmaceuticals worth $309K as of Q2 2026.
  • Plato Investment Management sold 8,583 Teva Pharmaceuticals shares in Q2 2026, an estimated $286K.
  • Teva Pharmaceuticals made up 0.02% of Plato Investment Management's portfolio in Q2 2026, its #380 holding.
  • Plato Investment Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Plato Investment Management's Teva Pharmaceuticals position peaked at $1.14M in Q3 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.